ArticleBriefings in bioinformatics2025
PepTCR-Net: prediction of multi-class antigen peptides by T-cell receptor sequences with deep learning.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modeling TCR-Epitope Recognition Specificity: What We Should Learn to Succeed.Immunological reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Predicting T-cell receptor (TCR) recognizing antigen peptides is crucial for understanding the immune system and developing new treatments for cancer, infectious and autoimmune diseases. As experimental methods for identifying TCR-antigen recognition are expensive and time-consuming, machine-learning approaches are increasingly used. However, existing computational tools often struggle with generalization due to limited data and challenges in acquiring true non-recognition pairs and rarely integrate multiple biological features into unified frameworks. To address these challenges, we propose a two-step framework for predicting TCR-antigen recognition. The first step focuses on feature engineering: neural network-based embeddings of letter-based TCR and peptide sequences inspired by language models, and categorical encoding of Human Leukocyte Antigen types and Variable/Joining genes. In the second step, we built a prediction model to assess the likelihood of TRC-antigen recognition by a Bayesian Feedforward Neural Network. We trained and validated the framework using large public databases. Our results demonstrate that our advanced feature engineering delivers strong predictive performance both internally and externally. We applied the framework to a real-world case for predicting whether specific TCRs can recognize SARS-CoV-2 epitope peptides, demonstrating that our framework can function as a de novo TCR-antigen prediction tool applicable to infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.